Browsing by Author Baran, Yusuf

Showing results 91 to 110 of 162 < previous   next >
Issue DateTitleAuthor(s)
Jun-2013Mechanisms Responsible for Nilotinib Resistance in Human Chronic Myeloid Leukemia Cells and Reversal of ResistanceCamgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Baran, Yusuf 
2015Mesenchymal Stem Cells Administered Intraperitoneally Have a Potent Effects on the Experimental Allergic Airway DiseaseIşık, S.; Adan, Aysun ; Karaman, M.; Kiray, M.; Bağrıyanık, H. A.; Çağlayan-Sözmen, S.; Uzuner, N.; Baran, Yusuf 
Aug-2011Mesenchymal Stem Cells Ameliorate the Histopathological Changes in a Murine Model of Chronic AsthmaFırıncı, Fatih; Karaman, Meral; Baran, Yusuf ; Bağrıyanık, Alper; Arıkan Ayyıldız, Zeynep; Kiray, Müge; Kozanoglu, İlknur; Yılmaz, Osman; Uzuner, Nevin; Karaman, Özkan
2015The Microarray Gene Profiling Analysis of Acute Promyelocytic Leukemia Cells in Response To Fisetin and HesperetinAdan Gökbulut, Aysun ; Baran, Yusuf 
2023Micrornas and Long Non-Coding Rnas as Novel Targets in Anti-Cancer Drug DevelopmentÇetinkaya, Melisa; Baran, Yusuf 
2018A Minimally Invasive Transfer Method of Mesenchymal Stem Cells To the Intact Periodontal Ligament of Rat Teeth: a Preliminary StudyGül Amuk, Nisa; Kurt, Gökmen; Kartal Yandım, Melis; Adan, Aysun ; Baran, Yusuf 
Apr-2013Mir-17 in Imatinib Resistance and Response To Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia CellsFıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf 
Feb-2016A Molecular and Biophysical Comparison of Macromolecular Changes in Imatinib-Sensitive and Imatinib-Resistant K562 Cells Exposed To PonatinibKartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf 
Jul-2016Molecular Mechanisms of Drug Resistance and Its Reversal in CancerKartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf 
Aug-2014Molecular Mechanisms of Quercitrin-Induced Apoptosis in Non-Small Cell Lung CancerÇinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia
2014Multidrug Resistance in Chronic Myeloid LeukemiaÜnlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf 
Feb-2009Multidrug Resistance Mediated by Mrp1 Gene Overexpression in Breast Cancer PatientsAbaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk
2012A Natural Product, Quercetin Enhances the Cytotoxic and Apoptotic Effects of Dexamethasone on Jurkat CellsBaran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur
Feb-2013New Indication for Therapeutic Potential of an Old Well-Known Drug (propranolol) for Multiple MyelomaKozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf 
Oct-2015Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic FashionKatgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden
Feb-2010Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells With Wild-Type Bcr-Abl, as Effectively as in Parental Sensitive CounterpartsEkiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf 
2009Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells, as Effectively as in Parental Sensitive CounterpartsBaran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan 
2012A Novel Agent, Kl-21, Has Significant Anticancer Potential on Chronic Lymphocytic Leukemia Cells but Not on Healthy CellsBaran, Yusuf ; Gökbulut, Aysun ; Yaşar, M.
Jan-2013Novel Agents Targeting Bioactive Sphingolipids for the Treatment of CancerAdan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf 
2014A Novel Biomarker for Drug Resistance in Chronic Myeloid Leukemia: Microrna-17Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali